• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析导管的封管溶液;肝素和枸橼酸盐——ASDIN立场文件

Locking solutions for hemodialysis catheters; heparin and citrate--a position paper by ASDIN.

作者信息

Moran John E, Ash Stephen R

机构信息

Satellite Healthcare, Mountain View, CA 94041, USA.

出版信息

Semin Dial. 2008 Sep-Oct;21(5):490-2. doi: 10.1111/j.1525-139X.2008.00466.x. Epub 2008 Aug 29.

DOI:10.1111/j.1525-139X.2008.00466.x
PMID:18764795
Abstract

There is wide variation in the use of solutions to "lock" or fill tunneled central venous catheters for dialysis. Some centers use undiluted heparin concentrations ranging from 1000 to 10,000 U/ml and other centers place from 1000 to 10,000 U per lumen. Based on available evidence, it appears that heparin 1000 U/ml, or 4% sodium citrate are suitable choices for lock solution to maintain patency of tunneled central venous catheters for dialysis. Risks from systemic anticoagulation are lower with heparin 1000 U/ml and 4% sodium citrate, compared with higher concentrations of heparin (5000 and 10,000 U/ml). The need for use of tissue plasminogen activator for maintaining catheter patency is increased by using heparin lock at 1000 U/ml, vs. higher concentrations. Higher concentrations of heparin lock should be reserved for patients who have evidence of catheter occlusion or thrombosis when heparin is used at 1000 U/ml. Similar choices for lock solution are sensible for acute hemodialysis catheters. When heparin is used for catheter lock, the injected volume should not exceed the internal volume of the catheter.

摘要

在用于“封管”或充盈透析用带隧道中心静脉导管的溶液使用方面存在很大差异。一些中心使用浓度范围为1000至10000 U/ml的未稀释肝素,而其他中心则在每个管腔内放置1000至10000 U肝素。根据现有证据,肝素1000 U/ml或4%柠檬酸钠似乎是维持透析用带隧道中心静脉导管通畅的封管溶液的合适选择。与较高浓度的肝素(5000和10000 U/ml)相比,肝素1000 U/ml和4%柠檬酸钠引起全身抗凝的风险较低。与较高浓度相比,使用1000 U/ml肝素封管会增加使用组织纤溶酶原激活剂来维持导管通畅的必要性。当使用1000 U/ml肝素时,较高浓度的肝素封管应保留给有导管堵塞或血栓形成证据的患者。对于急性血液透析导管,封管溶液的类似选择是合理的。当使用肝素进行导管封管时,注入的体积不应超过导管的内部容积。

相似文献

1
Locking solutions for hemodialysis catheters; heparin and citrate--a position paper by ASDIN.血液透析导管的封管溶液;肝素和枸橼酸盐——ASDIN立场文件
Semin Dial. 2008 Sep-Oct;21(5):490-2. doi: 10.1111/j.1525-139X.2008.00466.x. Epub 2008 Aug 29.
2
Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.肝素与枸橼酸盐作为急性肾衰竭需要肾脏替代治疗患者非隧道式中心静脉血液透析导管封管溶液的比较(VERROU-REA研究):一项随机对照试验的研究方案
Trials. 2014 Nov 19;15:449. doi: 10.1186/1745-6215-15-449.
3
Sodium citrate 4% locking solution for central venous dialysis catheters--an effective, more cost-efficient alternative to heparin.用于中心静脉透析导管的4%柠檬酸钠封管溶液——肝素的一种有效且更具成本效益的替代方案。
Nephrol Dial Transplant. 2007 Feb;22(2):471-6. doi: 10.1093/ndt/gfl606. Epub 2006 Oct 25.
4
Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.枸橼酸钠与肝素用于带 cuff 的中心静脉导管封管的比较:一项单中心随机对照试验。
Am J Kidney Dis. 2009 Jun;53(6):1034-41. doi: 10.1053/j.ajkd.2009.01.259. Epub 2009 Apr 25.
5
A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.一项比较庆大霉素/柠檬酸盐和肝素封管用于维持性血液透析患者中心静脉导管的随机试验。
Am J Kidney Dis. 2012 Jan;59(1):102-7. doi: 10.1053/j.ajkd.2011.08.031. Epub 2011 Nov 14.
6
The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study.头孢噻肟和肝素导管限制灌注对临时血液透析导管使用寿命的影响:一项病例对照研究。
J Nephrol. 2005 Nov-Dec;18(6):755-63.
7
Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.4%柠檬酸钠对比肝素作为带隧道和涤纶套中心静脉导管(CVC)的血液透析患者封管液。
Am J Health Syst Pharm. 2013 Jan 15;70(2):131-6. doi: 10.2146/ajhp120300.
8
Risk of bacterial contamination from citrate catheter locks.枸橼酸盐导管封管引起细菌污染的风险。
Semin Dial. 2009 Nov-Dec;22(6):704. doi: 10.1111/j.1525-139X.2009.00685.x.
9
Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction.肝素封管液浓度与中心静脉血液透析导管故障风险
ASAIO J. 2007 Jul-Aug;53(4):485-8. doi: 10.1097/MAT.0b013e3180619519.
10
Concentrated heparin lock is associated with major bleeding complications after tunneled hemodialysis catheter placement.在隧道式血液透析导管置入后,浓缩肝素封管与严重出血并发症相关。
Semin Dial. 2007 Jul-Aug;20(4):351-4. doi: 10.1111/j.1525-139X.2007.00294.x.

引用本文的文献

1
Impact of Heparin Hemodialysis Catheter Lock on Partial Thromboplastin Time Assays in Inpatients on Therapeutic Intravenous Heparin.肝素血液透析导管封管对接受静脉注射肝素治疗的住院患者部分凝血活酶时间测定的影响
Semin Dial. 2025 Jul-Aug;38(4):282-285. doi: 10.1111/sdi.13260. Epub 2025 Jun 5.
2
Strategies to Prevent Hemodialysis Catheter Dysfunction.预防血液透析导管功能障碍的策略。
J Am Soc Nephrol. 2025 May 1;36(5):952-966. doi: 10.1681/ASN.0000000666. Epub 2025 Feb 20.
3
Comparison of Tetrasodium EDTA 4% with Sodium Citrate 4% as Line-Locking Solutions at 2 Tertiary Hemodialysis Centres.
在两家三级血液透析中心比较4%乙二胺四乙酸四钠与4%柠檬酸钠作为管路封管液的效果
Can J Hosp Pharm. 2024 Jan 10;77(1):e3447. doi: 10.4212/cjhp.3447. eCollection 2024.
4
Effect of a Multifaceted Intervention on the Incidence of Hemodialysis Catheter Dysfunction in a National Stepped-Wedge Cluster Randomized Trial.一项全国性阶梯楔形整群随机试验中多方面干预对血液透析导管功能障碍发生率的影响
Kidney Int Rep. 2023 Jul 27;8(10):1941-1950. doi: 10.1016/j.ekir.2023.07.013. eCollection 2023 Oct.
5
Sodium bicarbonate is a potential alternative to classic heparin as a lock solution for non-tunneled dialysis catheters: a result from the prospective randomized BicarbLock trial.碳酸氢钠作为非隧道式透析导管封管溶液,是经典肝素的一种潜在替代方案:前瞻性随机双盲BicarbLock试验的结果
Int Urol Nephrol. 2024 Apr;56(4):1465-1474. doi: 10.1007/s11255-023-03821-9. Epub 2023 Oct 12.
6
Reevaluation of lock solutions for Central venous catheters in hemodialysis: a narrative review.血液透析中中心静脉导管固定方案的再评估:叙述性综述。
Ren Fail. 2022 Dec;44(1):1501-1518. doi: 10.1080/0886022X.2022.2118068.
7
May position of hemodialysis catheter tip have a direct effect on its patency? Positive results of a preliminary study on its rotation.血液透析导管尖端的位置会对其通畅性产生直接影响吗?关于其旋转的初步研究结果呈阳性。
Eur J Transl Myol. 2022 May 19;32(2):10537. doi: 10.4081/ejtm.2022.10537.
8
A Randomized Controlled Trial of Comparative Efficacy between Sodium Bicarbonate and Heparin as A Locking Solution for Tunneled Central Venous Catheters Among Patients Requiring Maintenance Hemodialysis.碳酸氢钠与肝素作为维持性血液透析患者隧道式中心静脉导管封管液的疗效比较随机对照试验
Can J Kidney Health Dis. 2021 Sep 30;8:20543581211046077. doi: 10.1177/20543581211046077. eCollection 2021.
9
Heparin Drug Shortage Conservation Strategies.肝素药物短缺的应对策略
Fed Pract. 2019 Oct;36(10):449-454.
10
Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trial.4%枸橼酸钠与肝素作为危重症患者非隧道式血液透析导管封管液的比较:一项多中心随机临床试验
Ann Intensive Care. 2019 Jul 1;9(1):75. doi: 10.1186/s13613-019-0553-4.